Welcure Drugs & Pharmaceuticals Limited

WELCURE.BO

WELCURE.BOWelcure Drugs & Pharmaceuticals Limited IN flag

Bombay Stock Exchange

11.06

INR

-0.58

(-4.98%)

0.36EPS

30.72P/E

1.24BMarket Cap

Upgrade to Unlock Non-US CompaniesTo view real-time data and analysis of companies outside of the United States, upgrade your account to our premium subscription.

Upgrade

ISIN

INE331C01017

Return %

Stock

S&P500

58.23

14.32

65.57

59.99

1,201.18

93.51

Use logarithmic scale

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	TTM
Revenue per Share	0.03	0.03	0.04	0.08	0.07	0.04	0.07	0.07	0.11	0.09	- -	- -	- -	3.6
Basic EPS, GAAP	0.01	- -	- -	0.07	0.02	-0.02	- -	-0.01	0.05	0.02	0.08	-0.13	- -	0.32
Free Cash Flow per Basic Share	0.01	- -	0.01	-0.04	0.02	-0.01	- -	-0.01	0.03	0.02	0.08	-0.09	- -	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Book Value per Share	-0.19	10	-0.19	-0.11	-0.09	-0.11	-0.1	-0.11	-0.07	-0.05	1.02	0.88	- -	16.48
Tangible Book Value per Share	-0.07	-0.07	-0.06	0.01	0.03	0.02	0.02	0.01	0.06	0.08	1.13	0.99	- -	15.03
Basic Weighted Avg Shares	12	12	12	12	12	12	12	12	12	12	13	14	- -	68
Sales/Revenue/Turnover	- -	- -	1	1	1	- -	1	1	1	1	- -	- -	246	246
Operating Margin (%)	29.75	4.53	6.9	82.21	30.8	-41	2.91	-11.88	41.26	22.52	- -	- -	3.54	3.54
Depreciation Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income, GAAP	- -	- -	- -	1	- -	- -	- -	- -	1	- -	1	-2	22	22
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	21.94	21.94
Profit Margin (%)	39.48	7.81	11.58	85.59	30.8	-38.8	4.88	-11.39	41.36	22.46	- -	- -	8.84	8.84
Working Capital	-1	-1	-1	- -	- -	- -	- -	- -	- -	1	- -	- -	1,409	1,409
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1,232	1,232
Total Equity	-1	-1	-1	- -	- -	- -	- -	- -	1	1	15	13	1,025	1,025
Return on Invested Capital (%)	- -	- -	- -	-263.49	108.66	- -	10.63	- -	130.47	29.11	-16.84	- -	0.6	0.6
Return on Capital (%)	-5.34	0.05	0.1	-47.02	-22.05	- -	-3.01	- -	-50.7	-33.97	15.56	- -	1.83	1.83
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-13.69	3.82	3.82

Capital Structure

•

in mil. unless spec.

Working Capital

•

in mil. unless spec.

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)	10 years	5 years	1 year
Sales/Revenue/Turnover	- -	- -	23,280.95%
Net Income, GAAP	-137.01%	-405.19%	-1,341.48%
Free Cash Flow	17,170.07%	34,716.6%	173,917.08%
Total Cash Common Dividend	- -	- -	- -
Total Equity	953.77%	1,896.99%	7,547.75%

Growth Rates

•

in mil. unless spec.

Quarterly Revenue

•

in mil. unless spec.

Quarterly Earnings Per Share

•

in mil. unless spec.

Quarterly Dividends Per Share

•

in mil. unless spec.

Company Description

CEO: Chintan Didawala Ganpat
Sector: Healthcare
Industry: Medical - Pharmaceuticals
Address: ‘Plot No. 55, Office No. 104 New Delhi India
IPO Date: Nov 27, 2000
Website: welcuredrugs.com
Similar Companies: Tecan Group AG (0QLN.L)
Welcia Holdings Co., Ltd. (WLCGF)
Zogenix, Inc. (0M3O.L)
Kimia Biosciences Ltd. (KIMIABL.BO)
ACI Global Corporation (ACGJ)
Nutroganics, Inc. (NUTTQ)
Business: Welcure Drugs & Pharmaceuticals Ltd. engages in the manufacture and trade of pharmaceutical and medical products. The company was founded by Dharam Chand Jain on June 4, 1992 and is headquartered in New Delhi, India.

	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y	TTM
Revenue per Share	0.03	0.03	0.04	0.08	0.07	0.04	0.07	0.07	0.11	0.09	- -	- -	- -	3.6
Basic EPS, GAAP	0.01	- -	- -	0.07	0.02	-0.02	- -	-0.01	0.05	0.02	0.08	-0.13	- -	0.32
Free Cash Flow per Basic Share	0.01	- -	0.01	-0.04	0.02	-0.01	- -	-0.01	0.03	0.02	0.08	-0.09	- -	- -
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Book Value per Share	-0.19	10	-0.19	-0.11	-0.09	-0.11	-0.1	-0.11	-0.07	-0.05	1.02	0.88	- -	16.48
Tangible Book Value per Share	-0.07	-0.07	-0.06	0.01	0.03	0.02	0.02	0.01	0.06	0.08	1.13	0.99	- -	15.03
Basic Weighted Avg Shares	12	12	12	12	12	12	12	12	12	12	13	14	- -	68
Sales/Revenue/Turnover	- -	- -	1	1	1	- -	1	1	1	1	- -	- -	246	246
Operating Margin (%)	29.75	4.53	6.9	82.21	30.8	-41	2.91	-11.88	41.26	22.52	- -	- -	3.54	3.54
Depreciation Expense	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Net Income, GAAP	- -	- -	- -	1	- -	- -	- -	- -	1	- -	1	-2	22	22
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	21.94	21.94
Profit Margin (%)	39.48	7.81	11.58	85.59	30.8	-38.8	4.88	-11.39	41.36	22.46	- -	- -	8.84	8.84
Working Capital	-1	-1	-1	- -	- -	- -	- -	- -	- -	1	- -	- -	1,409	1,409
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	1,232	1,232
Total Equity	-1	-1	-1	- -	- -	- -	- -	- -	1	1	15	13	1,025	1,025
Return on Invested Capital (%)	- -	- -	- -	-263.49	108.66	- -	10.63	- -	130.47	29.11	-16.84	- -	0.6	0.6
Return on Capital (%)	-5.34	0.05	0.1	-47.02	-22.05	- -	-3.01	- -	-50.7	-33.97	15.56	- -	1.83	1.83
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	-13.69	3.82	3.82

	Sep'25	Dec'25	Mar'25
ST Debt	- -	- -	- -
LT Borrowings	- -	- -	1,232
LT Finance Leases	- -	- -	- -
Preferred Equity and Hybrid Capital	- -	- -	- -
Shares Outstanding	79	- -	113
Market Capitalization	272	796	620

	Sep'25	Dec'25	Mar'25
Total Current Assets	2,684	- -	1,821
Accounts Receivable, Net	332	- -	190
Cash, Cash Equivalents & STI	2	- -	196
Inventories	1,435	- -	1,435
Total Current Liabilities	1,680	- -	413
Payables & Accruals	- -	- -	- -
ST Debt	- -	- -	- -
Deferred Revenue	- -	- -	- -

Welcure Drugs & Pharmaceuticals Limited

Growth Rates

(avg. rate of change)

Company Description

Growth Rates

(avg. rate of change)

Capital Structure

Working Capital

Quarterly Revenue

Year

Quarterly Earnings Per Share

Year

Quarterly Dividends Per Share

Year

Year	Q1	Q2	Q3	Q4	FY
2023	-0.04	- -	- -	- -	0.08
2024	-0.02	-0.07	-0.02	- -	-0.13
2025	-0.26	0.23	0.04	- -	- -